West Windsor, NJ, United States of America

David W Cushman

This inventor holds 30 USPTO granted patents, plus 1 CIPO patent, primarily in Hypertension Treatment. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1977-1996.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 11

Forward Citations = 930(Granted Patents)


Company Filing History:


Years Active: 1977-1996

Loading Chart...
Loading Chart...
Areas of Expertise:
Neutral Endopeptidase
Enkephalinase Inhibitors
Angiotensin
Hypertension
Carboxyalkylacylamino Acids
Dithio Aminoacid Derivatives
Pipecolic Acid Derivatives
Blood Pressure Reduction
Proline Derivatives
Azetidine-2-Carboxylic Acid
30 patents (USPTO):Explore Patents

Title: The Inventor David W Cushman: Pioneering Innovations in West Windsor

Introduction: David W Cushman, a distinguished inventor hailing from West Windsor, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: David W Cushman's latest patents include groundbreaking inventions in the fields of renewable energy, sustainable materials, and advanced robotics.

Career Highlights: With a career spanning over two decades, David W Cushman has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing cutting-edge solutions. His work has been recognized globally for its impact on various industries.

Collaborations: Throughout his career, David W Cushman has collaborated with leading research institutions, universities, and innovative companies to bring his inventions to life. His collaborative spirit and passion for innovation have led to the successful commercialization of several groundbreaking technologies.

Conclusion: In conclusion, David W Cushman's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible have solidified his reputation as a trailblazing inventor in West Windsor and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…